Nils Lonberg

Title: Nils Lonberg: Innovator in Recombinant Protein Production

Introduction

Nils Lonberg is a prominent inventor based in New York, NY (US), known for his significant contributions to the field of biotechnology. He holds two patents that focus on the production of recombinant proteins in mammalian milk, which have important implications for medical and therapeutic applications.

Latest Patents

Lonberg's latest patents include innovative methods for producing recombinant proteins in the milk of transgenic non-human mammals. The first patent, titled "Transgenic Non-Human Mammal Milk," describes an expression system that allows female mammals to produce various recombinant proteins, such as coagulation factors, growth hormones, and immunoglobulins, in their milk. This groundbreaking invention enables the isolation of these proteins for therapeutic use. The second patent, "Isolation of Exogenous Recombinant Proteins from the Milk of Transgenic," further elaborates on the use of a mammal's casein promoter to facilitate the production of desired recombinant proteins in milk. Both patents highlight Lonberg's expertise in genetic engineering and its applications in biotechnology.

Career Highlights

Throughout his career, Nils Lonberg has worked with leading companies in the biotechnology sector, including Biogen, Incorporated and Pharming B.V. His work has significantly advanced the field of recombinant protein production, making him a key figure in the industry.

Collaborations

Lonberg has collaborated with notable professionals in his field, including Harry M. Meade, enhancing the impact of his research and innovations.

Conclusion

Nils Lonberg's contributions to the field of biotechnology through his patents and career achievements underscore his role as an influential inventor. His work continues to pave the way for advancements in recombinant protein production, which holds great promise for medical applications.